30 results on '"Burghart, Lukas"'
Search Results
2. Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure
3. Autoimmune Lebererkrankungen
4. Imaging features facilitate diagnosis of porto-sinusoidal vascular disorder
5. THU-183-YI Immunosuppressive treatment facilitates hepatic recompensation in patients with decompensated cirrhosis due to autoimmune hepatitis-a pilot study
6. THU-381 Prognostic implications of liver stiffness impairment after HCV cure in cACLD patients
7. Letter: Fibrates may be safe and effective in patients with primary biliary cholangitis and decompensated cirrhosis—Authors' reply
8. Portal hypertension and its prognostic implications in patients with Wilson's disease
9. Editorial: Recompensation in PBC is good. But is it good enough? Authors' reply
10. Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitis
11. Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosis.
12. ELIMINATE: a PCR record-based macroelimination project for systematic recall of HCV-RNA-positive persons in Austria
13. Late-stage presentation with decompensated cirrhosis is alarmingly common but successful etiologic therapy allows for favorable clinical outcomes
14. The risks of first hepatic decompensation and HCC remain constant during long-term follow-up and can be stratified by a one-time assessment after HCV-cure
15. Validation and refinement of the Baveno VII criteria for risk stratification in compensated advanced chronic liver disease after HCV-cure
16. Clinical features of portal hypertension and their prognostic implication in patients with Wilson’s disease
17. Editorial: Tracking the course of Wilson's disease: Authors' reply.
18. Imaging features facilitate diagnosis of porto-sinusoidal vascular disorder
19. HCV hotline facilitates Hepatitis C elimination during the COVID ‐19 pandemic
20. ELIMINATE-interim results of an Austrian HCV macro-elimination project
21. Portal hypertension-associated clinical features in patients with primary biliary cholangitis are of distinct prognostic value
22. THU-166 Portal hypertension and its prognostic implications in patients with autoimmune hepatitis
23. Combining Treatment for Chronic Hepatitis C with Opioid Agonist Therapy is an Effective Microelimination Strategy for People Who Inject Drugs with High Risk of Non-Adherence to Antiviral Therapy
24. Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitis
25. TOP-055 - Clinical features of portal hypertension and their prognostic implication in patients with Wilson’s disease
26. SAT-521 - Validation and refinement of the Baveno VII criteria for risk stratification in compensated advanced chronic liver disease after HCV-cure
27. OS-127-YI - The risks of first hepatic decompensation and HCC remain constant during long-term follow-up and can be stratified by a one-time assessment after HCV-cure
28. Empagliflozin in posttransplantation diabetes mellitus: A prospective, interventional pilot study on glucose metabolism, fluid volume, and patient safety
29. Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure.
30. Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.